QHM-2025-9473 A86022 Parkway Medical Centre Enhanced Services Contract

The NHS North East and North Cumbria Integrated Care Board is set to award the contract titled "QHM-2025-9473 A86022 Parkway Medical Centre Enhanced Services Contract" under the Direct Award Process A as per the Health Care Services (Provider Selection Regime) regulations 2023. This procurement process involves health services, specifically targeting areas such as Care Homes DES+, Androgen Deprivation Injections, and Diabetes Shared Care, among others. The procurement process has reached the award stage with the contract signing dated 1 October 2025.

The contract is worth a nominal value of £0.01 due to it being an activity-based contract, and will be implemented in the UKC region from 1 April 2025 to 31 March 2026. Notably, the procurement method used here is a limited award procedure without prior publication, exempt from the Procurement Act 2023 and Procurement Regulations 2024. This tender offers significant growth opportunities for large-scale healthcare service providers, particularly those already established in the provision of complex health services within care home settings.

The contractual focus on specialised services such as diabetes management and PSA monitoring demonstrates potential interest areas for medical groups adept in these fields. Businesses with expertise in health service enhancements, such as Parkway Medical Group, the awarded supplier, are well positioned to compete in similar tender opportunities, benefiting from the stable demand within the public healthcare sector in the North East and North Cumbria region.